Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults

British Journal of Haematology

Volumn 124, Issue 4, 2004, Pages 488-498

  Hamza, Nashaat S ^a   Lisgaris, Michelle ^a   Yadavalli, Gopala ^a   Nadeau, Laura ^a   Fox, Robert ^a   Fu, Pingfu ^a   Lazarus, Hillard M ^a   Koc, Omer N ^a   Salata, Robert A ^a   Laughlin, Mary J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Allogeneic transplantation; Bacteraemia; Matched unrelated donor; Myeloid recovery; Umbilical cord blood

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; ETOPOSIDE; FLUCONAZOLE; GANCICLOVIR; HLA ANTIGEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; METHOTREXATE; METHYLPREDNISOLONE; NYSTATIN; PENTAMIDINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; SULFAMETHOXAZOLE; THYMOCYTE ANTIBODY; TRIMETHOPRIM;

ACUTE GRAFT REJECTION; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BONE MARROW CELL; BRAIN ABSCESS; CAUSE OF DEATH; CELL KINETICS; CHRONIC GRAFT REJECTION; CHRONIC MYELOID LEUKEMIA; CLOSTRIDIUM DIFFICILE; COLITIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DONOR; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; ENDOPHTHALMITIS; FEBRILE NEUTROPENIA; FEMALE; FUNGEMIA; FUNGUS; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HERPES SIMPLEX VIRUS; HLA MATCHING; HUMAN; INFECTION; LUNG ASPERGILLOSIS; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEPHROTOXICITY; NEUTROPENIA; NEUTROPHIL; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRIORITY JOURNAL; RELAPSE; RETINITIS; SEPSIS; SURVIVAL; UMBILICAL CORD BLOOD; URINARY TRACT INFECTION; VIRUS INFECTION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; BONE MARROW; FEMALE; FETAL BLOOD; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING;

EID: 10744225349     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04792.x     Document Type: Article

References (56)

1. Appelbaum, F.R. (1997) Allogeneic hematopoietic stem cell transplantation for acute leukemia. Seminars in Oncology, 24, 114-123.
2. Ascioglu, S., Rex, J.H., de Pauw, B., Bennett, J.E., Bille, J., Crokaert, F., Denning, D.W., Donnelly, J.P., Edwards, J.E., Erjavec, Z., Fiere, D., Lortholary, O., Maertens, J., Meis, J.F., Patterson, T.F., Ritter, J., Selleslag, D., Shah, P.M., Stevens, D.A. & Walsh, T.J. (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clinical Infectious Diseases, 34, 7-14.
3. Aversa, F., Tabilio, A., Velardi, A., Cunningham, I., Terenzi, A., Falzetti, F., Ruggeri, L., Barbabietola, G., Aristei, C., Latini, P., Reisner, Y. & Martelli, M.F. (1998) Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. New England Journal of Medicine, 339, 1186-1193.
4. Baddley, J.W., Stroud, T.P., Salzman, D. & Pappas, P.G. (2001) Invasive mold infections in allogeneic bone marrow transplant recipients. Clinical Infectious Diseases, 32, 1319-1324.
5. Barker, J.N. & Wagner, J.E. (2003) Umbilical-cord blood transplantation for the treatment of cancer. Nature Reviews. Cancer, 3, 526-532.
6. Barker, J.N., Davies, S.M., DeFor, T., Ramsay, N.K., Weisdorf, D.J. & Wagner, J.E. (2001) Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood, 97, 2957-2961.
7. Blume, K.G., Kopecky, K.J., Henslee-Downey, J.P., Forman, S.J., Stiff, P.J., LeMaistre, C.F. & Appelbaum, F.R. (1993) A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cydophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study. Blood, 81, 2187-2193.
8. Clift, R.A., Buckner, C.D., Thomas, E.D., Bensinger, W.I., Bowden, R., Bryant, E., Deeg, H.J., Doney, K.C., Fisher, L.D., Hansen, J.A., Martin, P., McDonald, G.B., Sanders, J.E., Schoch, G., Singer, J., Storb, R., Sullivan, K.M., Witherspoon, R.P. & Appelbaum, F.R. (1994) Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood, 84, 2036-2043.
9. Collin, B.A., Leather, H.L., Wingard, J.R. & Ramphal, R. (2001) Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clinical Infectious Diseases, 33, 947-953.
10. Copelan, E.A., Biggs, J.C., Szer, J., Thompson, J.M., Crilley, P., Brodsky, I., Klein, J.L., Kapoor, N., Harman, G.S. & Avalos, B.R. (1993) Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2). Seminars in Oncology, 20, 33-38.
11. Duval, M., Pedron, B., Rohrlich, P., Legrand, F., Faye, A., Lescoeur, B., Bensaid, P., Larchee, R., Sterkers, G. & Vilmer, E. (2002) Immune reconstitution after haematopoietic transplantation with two different doses of pre-graft antithymocyte globulin. Bone Marrow Transplant, 30, 421-426.
12. Dworkin, M.S. (2002) A review of progressive multifocal leukoencephalopathy in persons with and without AIDS. Current Clinical Topics in Infectious Diseases, 22, 181-195.
13. Engels, E.A., Ellis, C.A., Supran, S.E., Schmid, C.H., Barza, M., Schenkein, D.P., Koc, Y., Miller, K.B. & Wong, J.B. (1999) Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clinical Infectious Diseases, 28, 256-266.
14. Flowers, M.E., Kansu, E. & Sullivan, K.M. (1999) Pathophysiology and treatment of graft-versus-host disease. Hematology/Oncology Clinics of North America, 13, 1091-1112.
15. Gluckman, E., Rocha, V., Boyer-Chammard, A., Locatelli, F., Arcese, W., Pasquini, R., Ortega, J., Souillet, G., Ferreira, E., Laporte, J.P., Fernandez, M. & Chastang, C. (1997) Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. New England Journal of Medicine, 337, 373-381.
16. Howard, D.S., Phillips, I.G., Reece, D.E., Munn, R.K., Henslee-Downey, J., Pittard, M., Barker, M. & Pomeroy, C. (1999) Adenovirus infections in hematopoietic stem cell transplant recipients. Clinical Infectious Diseases, 29, 1494-1501.
17. Hughes, W.T., Armstrong, D., Bodey, G.P., Bow, E.J., Brown, A.E., Calandra, T., Feld, R., Pizzo, P.A., Rolston, K.V., Shenep, J.L. & Young, L.S. (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clinical Infectious Diseases, 34, 730-751.
18. Inoue, H., Yasuda, Y., Hattori, K., Shimizu, T., Matsumoto, M., Yabe, M., Yabe, H., Tsuchida, F., Tanaka, Y., Hosoi, G., Sako, M. & Kato, S. (2003) The kinetics of immune reconstitution after cord blood transplantation and selected CD34+ stem cell transplantation in children: comparison with bone marrow transplantation. International Journal of Hematology, 77, 399-407.
19. Jantunen, E., Ruutu, P., Niskanen, L., Volin, L., Parkkali, T., Koukila-Kahkola, P. & Ruutu, T. (1997) Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant, 19, 801-808.
20. Jaroscak, J., Goltry, K., Smith, A., Waters-Pick, B., Martin, P.L., Driscoll, T.A., Howrey, R., Chao, N., Douville, J., Burhop, S., Fu, P. & Kurtzberg, J. (2003) Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood, 101, 5061-5067.
21. Kaplan, E. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal American Statistical Association, 53, 457-481.
22. Kernan, N.A., Bartsch, G., Ash, R.C., Beatty, P.G., Champlin, R., Filipovich, A., Gajewski, J., Hansen, J.A., Henslee-Downey, J., McCullough, J., McGlave, P., Perkins, H.A., Phillips, G.L., Sanders, J., Stroncek, D., Thomas, E.D. & Blume, K.G. (1993) Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New England Journal of Medicine, 328, 593-602.
23. Ketterer, N., Espinouse, D., Chomarat, M., Dumontet, C., Moullet, I., Rieux, C., Neidhardt-Berard, E.M., Bouafia, F., Coiffier, B. & Salles, G. (1999) Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors. American Journal of Medicine, 106, 191-197.
24. Kumar, S., Chen, M.G., Gastineau, D.A., Gertz, M.A., Inwards, D.J., Lacy, M.Q., Tefferi, A. & Litzow, M.R. (2001) Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplant, 28, 951-956.
25. Kurtzberg, J., Laughlin, M., Graham, M.L., Smith, C., Olson, J.F., Halperin, E.C., Ciocci, G., Carrier, C., Stevens, C.E. & Rubinstein, P. (1996) Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. New England Journal of Medicine, 335, 157-166.
26. Laughlin, M.J., Barker, J., Bambach, B., Koc, O.N., Rizzieri, D.A., Wagner, J.E., Gerson, S.L., Lazarus, H.M., Cairo, M., Stevens, C.E., Rubinstein, P. & Kurtzberg, J. (2001) Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. New England Journal of Medicine, 344, 1815-1822.
27. Leather, H.L. & Wingard, J.R. (2001) Infections following hematopoietic stem cell transplantation. Infectious Disease Clinics of North America, 15, 483-520.
28. Lennard, A.L. & Jackson, G.H. (2000) Stem cell transplantation. British Medical Journal, 321, 433-437.
29. Ljungman, P., Griffiths, P. & Paya, C. (2002) Definitions of cytomegalovirus infection and disease in transplant recipients. Clinical Infectious Diseases, 34, 1094-1097.
30. Marr, K.A., Carter, R.A., Boeckh, M., Martin, P. & Corey, L. (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood, 100, 4358-4366.
31. McCullagh, P. & Neider, J. (1989) Generalized Linear Models. Chapman and Hall, London.
32. McGlave, P.B., Shu, X.O., Wen, W., Anasetti, C., Nademanee, A., Champlin, R., Antin, J.H., Kernan, N.A., King, R. & Weisdorf, D.J. (2000) Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program. Blood, 95, 2219-2225.
33. McWhinney, P.H., Kibbler, C.C., Hamon, M.D., Smith, O.P., Gandhi, L., Berger, L.A., Walesby, R.K., Hoffbrand, A.V. & Prentice, H.G. (1993) Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clinical Infectious Diseases, 17, 397-404.
34. Mermel, L.A., Farr, B.M., Sherertz, R.J., Raad, I.I., O'Grady, N., Harris, J.S. & Craven, D.E. (2001) Guidelines for the management of intravascular catheter-related infections. Clinical Infectious Diseases, 32, 1249-1272.
35. Morrison, V.A., Haake, R.J. & Weisdorf, D.J. (1994) Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. American Journal of Medicine, 96, 497-503.
36. Ninin, E., Milpied, N., Moreau, P., Andre-Richet, B., Morineau, N., Mahe, B., Vigier, M., Imbert, B.M., Morin, O., Harousseau, J.L. & Richet, H. (2001) Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clinical Infectious Diseases, 33, 41-47.
37. Ochs, L., Shu, X.O., Miller, J., Enright, H., Wagner, J., Filipovich, A., Miller, W. & Weisdorf, D. (1995) Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood, 86, 3979-3986.
38. Ooi, J., Iseki, T., Takahashi, S., Tomonari, A., Nagayama, H., Ishii, K., Ito, K., Sato, H., Takahashi, T., Shindo, M., Sekine, R., Ohno, N., Uchimaru, K., Nagamura, F., Shirafuji, N., Tojo, A., Tani, K. & Asano, S. (2002) A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukaemia in complete remission. British Journal of Haematology, 118, 140-143.
39. Osorio, S., De La Camara, R., Golbano, N., Marti, E., Fedele, C.G., Nieto, S., Manzanares, R. & Fernandez-Ranada, J.M. (2002) Progressive multifocal leukoencephalopathy after stem cell transplantation, unsuccessfully treated with cidofovir. Bone Marrow Transplant, 30, 963-966.
40. Pavletic, Z.S., Joshi, S.S., Pirruccello, S.J., Tarantolo, S.R., Kollath, J., Reed, E.G., Bierman, P.J., Vose, J.M., Warkentin, P.I., Gross, T.G., Nasrati, K., Armitage, J.O., Kessinger, A. & Bishop, M.R. (1998) Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant, 21, 33-41.
41. Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H., Beatty, P., Hows, J. & Thomas, E. (1995) 1994 consensus conference on acute GVHD grading. Bone Marrow Transplantation, 15, 825-828.
42. Rocha, V.C.J., Sievers, E.L., Filipovich, A., Locatelli, F., Pters, C., Remberger, M., Michel, G., Arcese, W., Dallorso, S., Tiedemann, K., Busca, A., Chan, K.W., Kato, S., Ortega, J., Vowels, M., Zander, A., Souillet, G., Oakill, A., Woolfrey, A., Pay, A.L., Green, A., Garnier, F., Ionescu, I., Wernet, P., Sirchia, G., Rubinstein, P., Chevret, S. & Gluckman, E. (2001) Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood, 97, 2962-2971.
43. Rubinstein, P., Dobrila, L., Rosenfield, R.E., Adamson, J.W., Migliaccio, G., Migliaccio, A.R., Taylor, P.E. & Stevens, C.E. (1995) Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proceedings of the National Academy of Sciences of the USA, 92, 10 119-10 122.
44. Rubinstein, P., Carrier, C., Scaradavou, A., Kurtzberg, J., Adamson, J., Migliaccio, A.R., Berkowitz, R.L., Cabbad, M., Dobrila, N.L., Taylor, P.E., Rosenfield, R.E. & Stevens, C.E. (1998) Outcomes among 562 recipients of placental-blood transplants from unrelated donors. New England Journal of Medicine, 339, 1565-1577.
45. Saavedra, S., Sanz, G.F., Jarque, I., Moscardo, F., Jimenez, C., Lorenzo, I., Martin, G., Martinez, J., De La Rubia, J., Andreu, R., Molla, S., Llopis, I., Fernandez, M.J., Salavert, M., Acosta, B., Gobernado, M. & Sanz, M.A. (2002) Early infections in adult patients undergoing unrelated donor cord blood transplantation. Bone Marrow Transplant, 30, 937-943.
46. Shpall, E.J., Quinones, R., Giller, R., Zeng, C., Baron, A.E., Jones, R.B., Bearman, S.I., Nieto, Y., Freed, B., Madinger, N., Hogan, C.J., Slat-Vasquez, V., Russell, P., Blunk, B., Schissel, D., Hild, E., Malcolm, J., Ward, W. & McNiece, I.K. (2002) Transplantation of ex vivo expanded cord blood. Biology of Blood and Marrow Transplantation, 8, 368-376.
47. Sobocinski, K.A., Horowitz, H.M., Rowlings P.A., Zhang, M.J., Nugent, M.L., Passweg, J.R., Armitage, J.O., Gale, R.P. & Bortin, M.M. (1994) Bone marrow transplantation-1994: a report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. Journal of Hematotherapy, 3, 95-102.
48. Sokal, J.E., Baccarani, M., Russo, D. & Tura, S. (1988) Staging and prognosis in chronic myelogenous leukemia. Seminars in Hematology, 25, 49-61.
49. Sokos, D.R., Berger, M. & Lazarus, H.M. (2002) Intravenous immunoglobulin: appropriate indications and uses in hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 8, 117-130.
50. Takenaka, K., Gondo, H., Tanimoto, K., Nagafuji, K., Fujisaki, T., Mizuno, S., Miyamoto, T., Okamura, T., Hayashi, S., Eto, T., Osaki, K., Yamasaki, K., Shibuya, T., Harada, N., Teshima, T., Matsuishi, E., Minematsu, T., Minamishima, Y., Harada, M. & Niho, Y. (1997) Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group. Bone Marrow Transplant, 19, 241-248.
51. Tomonari, A., Iseki, T., Ooi, J., Takahashi, S., Shindo, M., Ishii, K., Nagamura, F., Uchimaru, K., Tani, K., Tojo, A. & Asano, S. (2003) Cytomegalovirus infection following unrelated cord blood transplantation for adult patients: a single institute experience in Japan. British Journal of Haematology, 121, 304-311.
52. Walter, E.A. & Bowden, R.A. (1995) Infection in the bone marrow transplant recipient. Infectious Disease Clinics of North America, 9, 823-847.
53. Weber, T., Weber, F., Petry, H. & Luke, W. (2001) Immune response in progressive multifocal leukoencephalopathy: an overview. Journal of Neurovirology, 7, 311-317.
54. Wingard, J.R. (1999) Opportunistic infections after blood and marrow transplantation. Transplant Infectious Disease, 1, 3-20.
55. Yeghen, T., Kibbler, C.C., Prentice, H.G., Berger, L.A., Wallesby, R.K., McWhinney, P.H., Lampe, F.C. & Gillespie, S. (2000) Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution. Clinical Infectious Diseases, 31, 859-868.
56. Zaia, J.A. & Forman, S.J. (1995) Cytomegalovirus infection in the bone marrow transplant recipient. Infectious Disease Clinics of North America, 9, 879-900.